Omega Fund VI, L.P. 13D/13G Filings for Checkmate Pharmaceuticals, Inc. (CMPI)

Omega Fund VI, L.P. 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-12
2:13 pm
Purchase		 2020-08-11 13G Checkmate Pharmaceuticals, Inc.
CMPI		 Omega Fund VI, L.P. 1,335,050
6.200%		 1,335,050increase
(New Position)		 Filing